IFN-γ enhances killing of methicillin-resistant Staphylococcus aureus by human monocytes more effectively than GM-CSF in the presence of daptomycin and other antibiotics

Cytokine

Volumn 51, Issue 3, 2010, Pages 274-277

  Smith, Raymond P ^a,b   Baltch, Aldona L ^a,b   Ritz, William J ^a,b   Michelsen, Phyllis B ^a,b   Bopp, Lawrence H ^a,c  

^a STRATTON VA MEDICAL CENTER   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c Center for Agriculture and Natural Resources   (United States)

Author keywords

Antibiotics; Daptomycin; GM CSF; IFN ; Monocyte

Indexed keywords

CYTOKINE; DAPTOMYCIN; GAMMA INTERFERON; GENTAMICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RIFAMPICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOLYSIS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INTRACELLULAR KILLING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; CFU COUNTING; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MICROBIOLOGY;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; COLONY-FORMING UNITS ASSAY; DAPTOMYCIN; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-GAMMA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MONOCYTES;

EID: 77955274188     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.06.004     Document Type: Article

References (24)

1. Brouillette E., Grondin G., Shkreta L., Lacasse P., Talbot B.G. In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin binding proteins. Microb Pathog 2003, 35:159-168.
2. van den Broeck P.J., Seymonsbergen E.M. The influence of human granulocytes and monocytes on the antibacterial activity of cefetamet against Staphylococcus aureus. J Antimicrob Chemother 1995, 35:611-622.
3. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicilin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia. Clin Inf Dis 2003, 36:53-59.
4. Baltch A.L., Ritz W.J., Bopp L.H., Michelsen P., Smith R.P. Activities of Dap and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small colony variant in human monocyte-derived macrophages and in broth. Antimicrob Agents Chemother 2008, 52:1829-1833.
5. Murphy K., Travers P., Walport M. Janeway's immunobiology 2008, Garland Science, New York, pp. 349-361. 7th ed.
6. Carr R., Modi N., Doré C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev 2003, 3. CD 003,066.
7. Hübel K., Dale D.C., Liles W.C. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-γ. J Infect Dis 2002, 185:1490-1501.
8. Mock C.N., Dries D.J., Jurkovich G.J., Maier R.V. Assessment of two clinical trials: interferon-gamma therapy in severe injury. Shock 1996, 5:235-240.
9. Carr R., Brocklehurst P., Dore' C.J., Modi N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates [the PROGRAMS trial]: a single-blind, multicentre, randomized controlled trial. Lancet 2009, 373:226-233.
10. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically; approved standard. CLSI document M7-A7, 7th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
11. Baltch A.L., Ritz W., Bopp L.A., Michelsen P.B., Smith R.P. Antimicrobial activities of Dap, vancomycin and oxacillin in human monocyte, and Dap in combination with Gen and/or Rif in human monocytes and in broth against Staphylococcus aureus. Antimicrob Agents Chemother. 2007, 51:1559-1562.
12. Stuart A., Ord J.K. Kendall's advanced theory of statistics, vol. 2, p. 1124, table 29.2 1991, Oxford University Press, New York, NY.
13. Stuart A., Ord J.K. Kendall's advanced theory of statistics, vol. 2, p. 1149, section 29.58 1991, Oxford University Press, New York, NY.
14. McKenna P, Nelson S, Anderson J. Filgrastim [rHug-CSF] enhances ciprofloxacin uptake and bactericidal activity of human neutrophils in vitro. In: Abstracts of the annual meeting of the American Thoracic Society, New Orleans, LA. American Thoracic Society, New Orleans, LA, USA 1996;535:153.
15. Ouadrhiri Y., Scorneaux B., Sibille Y., Tulkens P.M. Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob Agents Chemother 1993, 43:1242-1251.
16. van der Auwera P., Matsumoto T., Husson M. Intraphagocytic penetration of antibiotics. J Antimicrob Chemother 1988, 22:185-195.
17. Lemaire S., Kosowska-Shick K., Julian K., Tulkens P.M., Van Bambeke F., Appelbaum P.C. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis. Clin Microbiol Infect 2008, 14:766-777.
18. Hoang A.N., Denis O., Vergison A., Theunis A., Tulkens P.M., Struelens M.J., et al. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogeneic normal-phenotype and revertant strains. Antimicrob Agents Chemother 2009, 54:1434-1442.
19. Nguyen H.A., Denis O., Vergison A., Theunis A., Tulkens P.M., Struelens M.J. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations. Antimicrob Agents Chemother 2009, 53:1443-1449.
20. Lemaire S., Van Bambeke F., Mingeot-Leclercq M.P., Tulkens P.M. Modulation of the cellular accumulation and intracellular activity of Dap towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells. Antimicrob Agents Chemother 2007, 51:2748-2757.
21. Martin E., Nathan C., Xie Q.W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994, 180:977-984.
22. Gaviria J.M., van Burik J.H., Dale D.C., Root R.K., Liles W.C. Comparison of Interferon-γ, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis 1999, 179:1038-1041.
23. Maródi L., Káposzta R., Nemes E. Survival of group B streptococcus type III in mononuclear phagocytes: differential regulation of bacterial killing in cord macrophages by human recombinant gamma interferon and granulocyte-macrophage colony-stimulating factor. Infect Immun 2000, 68:2167-2170.
24. Yamamoto Y., Klein T.W., Tomioka M., Friedman H. Differential effects of granulocyte/macrophage colony-stimulating factor [GM-CSF] in enhancing macrophage resistance to Legionella pneumophila vs. Candida albicans. Cell Immunol 1997, 176:75-81.